American Gastroenterological Association - Advancing the Science and Practice of Gastroenterology

Intestinal Disorders

Dear Member of the Intestinal Disorders Section and interested others:

We thank you for attending the 41st annual DDW® in New Orleans, LA and making it a scientifically relevant and exciting meeting! If you have specific feedback regarding speakers sponsored by the Intestinal Disorders (ID) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2011 in Chicago.

Two of our section's abstracts were presented in the highly successful AGA plenary sessions. "Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients with Chronic Constipation: Results from 2 Randomized, Double-blind, Placebo-controlled Phase 3 Trials" was presented at the main AGA Institute Clinical Science Plenary Session. "Altered Gut Microbiota in Toll-Like Receptor-5 (TLR5) Deficient Mice Results in Metabolic Syndrome" was presented at the main AGA Institute Basic Science Plenary Session.

This year the ID section accepted the majority of the abstracts submitted. The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers.

ID sponsored Clinical, Translational, and Research Symposia, and abstract based Research and Topic Fora, as well as one State of the Art Lecture. New this year the ID section sponsored Barrier and Immune Function of the Intestinal Epithelium: An Interactive Topic Forum on May 4, 2010 from 2:15 - 3:45pm. This session included a panel discussion and highlighted abstracts representing this year's greatest scientific advancements in this particular field. Below is a listing of the ID section programing for 2010 with the level of attendance indicated. As you can see, in general, ID sessions were extremely well attended this year.

Each June, ID section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute Sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (ID descriptors may change as we go forward to DDW 2011.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Intestinal Disorders were shared at DDW.

Section leaders will review committee membership this summer for abstract review committees to confirm the final composition for DDW 2011 committees.

Here are three ways to get involved:

1. If you are interested in serving as a reviewer for any of our abstract descriptors, please let us know. Please cite the abstract descriptor for which you would be interested in reviewing. Please recommend any new descriptors for abstracts.
2. Please submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please forward your suggestions to John Whiton, AGA Institute by July 6, 2010.
3. Members interested in participating in the various activities of the Section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.

Thank you for your continuing strong support of the Intestinal Disorders Section.

Sincerely,

Gary D. Wu, MD
Chair, ID Section, AGA Institute Council

Jerrold R. Turner, MD, PhD, AGAF
Vice-Chair, ID Section, AGA Institute Council